Fat reduction using phosphatidylcholine/sodium deoxycholate injections: Standard of practice

46Citations
Citations of this article
59Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The practice of injecting phosphatidylcholine/sodium deoxycholate compounds into subcutaneous fat is growing rapidly. As with any new procedure, a standard of practice should be developed so that practitioners maintain patient safety as the primary goal. Efficacy and predictability of outcome are another priority. As injection lipolysis, also known as "lipodissolve," becomes more accepted, many standards are being set, such as indications, contraindications, acceptable postinjection sequelae, best regions to treat, regions to avoid, and expected outcomes. This article establishes a basis of practice for the practitioner interested in adding this procedure to his or her repertoire. © 2008 Springer Science+Business Media, LLC and International Society of Aesthetic Plastic Surgery.

Cite

CITATION STYLE

APA

Duncan, D. I., & Palmer, M. (2008). Fat reduction using phosphatidylcholine/sodium deoxycholate injections: Standard of practice. Aesthetic Plastic Surgery, 32(6), 858–872. https://doi.org/10.1007/s00266-008-9188-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free